1.. Introduction {#s1}
================

The insulin/IGF-like signalling (IIS) pathway is ubiquitous in multi-cellular animals and may have been involved in the evolution of multi-cellularity itself ([@RSPB20090778C55]). The pathway, via a conserved intracellular signalling cascade including phosphatidylinositol-3-kinase (PI3K) and protein kinase B (PKB or AKT), negatively regulates the activity of several transcription factors of the forkhead family, by their phosphorylation and subsequent exclusion from the nucleus. Mutations that reduce the activity of the IIS signalling cascade have pleiotropic effects on many traits, including growth ([@RSPB20090778C5]; [@RSPB20090778C8]; [@RSPB20090778C27]; [@RSPB20090778C50]), development ([@RSPB20090778C33]), metabolic homeostasis ([@RSPB20090778C51]), adult lifespan, resistance to stress ([@RSPB20090778C35]; [@RSPB20090778C9]; [@RSPB20090778C24]) and fecundity ([@RSPB20090778C44]; [@RSPB20090778C34]; [@RSPB20090778C40]; [@RSPB20090778C63]; [@RSPB20090778C6]; [@RSPB20090778C45]) in the nematode worm *Caenrhabditis elegans*, the fruitfly *Drosophila melanogaster* and the mouse *Mus musculus*. Natural variation in some ecologically significant traits has also been found to be associated with IIS. For example, allelic variants of the PI3K are implicated in the latitudinal variation of reproductive diapause in *Drosophila melanogaster* ([@RSPB20090778C70]).

A primary function of IIS is to match energetically demanding activities such as growth and reproduction to nutrition and other informative environmental inputs such as various stresses, and to ensure metabolic homeostasis. Thus, consistent with its role in nutrient and stress sensing, a variety of extrinsic factors can be important regulators of insulin sensitivity in animals and humans. For example, the stress-responsive Jun-N-terminal kinase (JNK) pathway regulates IIS, linking responses to environmental stresses with metabolic homeostasis (see [@RSPB20090778C32] for review). In both *C. elegans* and *Drosophila*, genetically upregulating JNK signalling leads to decreased IIS, increased resistance to oxidative stress and extension of lifespan ([@RSPB20090778C41]; [@RSPB20090778C68]). The evolutionarily conserved nutrient-sensing TOR pathway regulates protein synthesis and growth in response to amino acids and growth factors ([@RSPB20090778C72]), and interacts with IIS to control lifespan in worms and flies ([@RSPB20090778C66]; [@RSPB20090778C29]; [@RSPB20090778C31]). In humans, diet ([@RSPB20090778C48]), stress ([@RSPB20090778C13]) and exercise ([@RSPB20090778C11]) have all been shown to affect insulin sensitivity. Acute (transient) insensitivity can also be experienced following infections and injuries in humans ([@RSPB20090778C28]; [@RSPB20090778C12]; [@RSPB20090778C65]), and, in *Drosophila*, infection by pathogenic *Mycobacterium* has been found to alter IIS ([@RSPB20090778C14]).

Another possible infectious extrinsic factor modifying IIS in *Drosophila* is *Wolbachia pipientis*, a micro-organism of the rickettsial family. *Wolbachia* is a widespread endosymbiont of arthropods and often causes infection-induced reproductive incompatibility in the host. This *Wolbachia*-induced trait has been found to occur in many *Drosophila* species, including *D. melanogaster* ([@RSPB20090778C4]; [@RSPB20090778C67]; [@RSPB20090778C38]). *Wolbachia* infection can also affect other aspects of host reproduction, and feminization, male killing and parthenogenesis have all been reported ([@RSPB20090778C60]; [@RSPB20090778C25]). Although the relationship between *Wolbachia* and the host species is usually symbiotic, a virulent form of *Wolbachia* that shortens lifespan has been found in *D. melanogaster* ([@RSPB20090778C39]). In the Bloomington stock centre, 30 per cent of *D. melanogaster* strains have been estimated to be infected by endosymbionts ([@RSPB20090778C10]). Removal of *Wolbachia* by tetracycline treatment showed that it was involved in the sterility of the *Sxl*^*4*^ mutant allele ([@RSPB20090778C58]) and the lifespan-extension phenotype of an *Indy* mutant stock ([@RSPB20090778C64]). The mechanisms involved in these effects of *Wolbachia* are not yet understood.

In the course of specifying and standardizing the *Wolbachia* infection status of our *D. melanogaster* laboratory stocks, we observed that the removal of *Wolbachia* by tetracycline appeared to exacerbate IIS mutant phenotypes. We therefore made a systematic investigation by measuring the effect of *Wolbachia* infection status on a range of IIS-related phenotypes in control and IIS mutant flies. In the presence of *Wolbachia*, ubiquitous expression of a dominant negative form of the insulin receptor (InRDN) resulted in moderate dwarfism, reduced fecundity and extension of female lifespan, all typical phenotypes of reduced IIS. In the absence of *Wolbachia*, the previously moderate effects of InRDN expression were accentuated, resulting in flies that showed severe IIS-related phenotypes including extreme dwarfism, sterility, increased fat levels and shortened lifespan. The absence of *Wolbachia* in control genotypes resulted in a decrease in fecundity and adult weight compared with infected control genotypes, but no effect on other IIS-related phenotypes. These data suggest that *Wolbachia* can increase IIS in infected flies.

2.. Material and methods {#s2}
========================

(a). Fly stocks and husbandry {#s2a}
-----------------------------

yw;UAS-dInR^A1409K^ (chr. II) was obtained from the Bloomington *Drosophila* Stock Centre (BDSC; ref. number. FBal0156359). The UAS-InRDN transgene causes an amino acid substitution in the kinase domain (R1409A) of the *Drosophila* insulin receptor (dInR), resulting in its dominant negative activity ([@RSPB20090778C71]). w^1118^; Daughterless-GAL4 (chr. III) (Fly Base ID FBti0013991) was obtained from the BDSC. UAS-PTEN was provided by Prof. Ernst Hafen (ETH, Switzerland), and w^1118^;;S~1~,106-GeneSwitch (chr. III) is described in [@RSPB20090778C16]. The *white*^Dahomey^ (*w*^Dah^) background stock is described in [@RSPB20090778C6]. The parental GAL4 and UAS strains used to generate experimental and control genotypes were backcrossed to our laboratory control strain *w*^Dah^ (*Wolbachia*-infected) to standardize genetic background, beginning with an initial cross between *w*^Dah^ females and transgenic males, followed by five subsequent backcrosses between transgenic females and *w*^Dah^ males. All stocks were maintained and experiments performed on standard sugar/yeast food as described in [@RSPB20090778C2], except food containing 160 g l^−1^ yeast was used for GeneSwitch experiments using Mifepristone (RU486, Sigma).

(b). Generation of *Wolbachia*-infected and -uninfected flies {#s2b}
-------------------------------------------------------------

PCR to detect the *wsp* gene ([@RSPB20090778C73]) confirmed that, after backcrossing, all stocks were infected with *Wolbachia* (Wol+; data not shown). To create genetically identical *Wolbachia*-uninfected stocks (Wol−), the backcrossed Wol+ GAL4, UAS and *w*^Dah^ strains were treated with 30 µg ml^−1^ of tetracycline contained in standard food for two generations and retested by PCR to confirm that *Wolbachia* had been removed ([figure 1](#RSPB20090778F1){ref-type="fig"}*a*). All stocks were then cultured under normal conditions for at least five generations to allow full recovery from the effects of tetracycline treatment and to restore intestinal flora ([@RSPB20090778C23]; [@RSPB20090778C64]) prior to the generation of *Wolbachia*-infected and -uninfected daGAL4/UAS-InRDN, daGAL4/+, UAS-InRDN/+ and *w*^Dah^ genotypes for further analysis.

![The effect of *Wolbachia* infection status on weight and fecundity of IIS mutant and control female flies. (*a*) PCR to the *wsp* gene demonstrating the removal of *Wolbachia* from parental strains. Positive control was genomic DNA obtained from tetracycline-untreated *w*^Dah^ strain. (*b*) The body weight of 7-day-old adult females was examined (*n* = 12): Wol+ w^Dah^ = 1.819 mg; Wol− *w*^Dah^ = 1.628 mg; Wol+ InRDN/+ = 1.829 mg; Wol− InRDN/+ = 1.683 mg; Wol+ daGAL4/dInRDN = 1.239 mg; Wol− daGAL4/dInRDN = 0.727 mg; Wol+ daGAL4/+ = 1.83 mg; and Wol− daGAL4/+ = 1.66 mg. Black bars, *Wolbachia*-infected; grey bars, -uninfected. (*c*) Average number of eggs laid per female per day at two weeks of age (*n* = 8 vials of 10 flies): Wol+ *w*^Dah^ = 62.76 eggs; Wol− *w*^Dah^ = 50.65 eggs; Wol+ InRDN/+ = 62.72 eggs; Wol− InRDN/+ = 52.53 eggs; Wol+ daGAL4/InRDN = 27.7 eggs; Wol− daGAL4/InRDN = 1.98 eggs; Wol+ daGAL/+ = 63.73 eggs; and Wol− daGAL/+ = 49.1 eggs. (*b*,*c*) Weight and fecundity data were subjected to two-way ANOVAs. Genotype (*p* \< 0.0001) and *Wolbachia* status (*p* \< 0.0001) had significant effects on both phenotypes, and there was a significant interaction effect on weight (*p* = 0.0238) and fecundity (*p* \< 0.0001). Planned comparisons of weight and fecundity by genotype in Wol+ or Wol− backgrounds were performed using the Tukey HSD, *p* \< 0.05. Error bars are s.e.m. and asterisk indicates significant difference from genetic controls. The statistical analyses of planned comparisons of weight and fecundity by *Wolbachia* status for each genotype are shown in [table 1](#RSPB20090778TB1){ref-type="table"}.](rspb20090778f01){#RSPB20090778F1}

(c). Lifespan experiments {#s2c}
-------------------------

Procedures for lifespan studies were as described in [@RSPB20090778C9]) and [@RSPB20090778C37]). The experimental flies were allowed to mate for 48 h before collection and sorting. Lifespans were measured in flies kept at 10 per vial on standard food medium and transferred to new food three times a week. Deaths were scored five to six times in every 7 days.

(d). Fecundity and body weight {#s2d}
------------------------------

Females for measuring body weight were prepared as for lifespan experiments and weighed individually when 7 days old. For fecundity, the number of eggs laid per vial of 10 females per day in lifespan experiments was counted.

(e). Triacylglycerol assay {#s2e}
--------------------------

Triacylglyceride (TAG) content quantification was performed as described in [@RSPB20090778C19], except that data were normalized to whole fly weight.

(f). Oil red O staining {#s2f}
-----------------------

Lipid droplets were stained with Oil Red O (Sigma; [@RSPB20090778C20]). Seven-day-old (adult) female abdomens were attached to a glass slide using double-sided tape and dissected to expose the adult fat body attached to the dorsal abdomen. Samples were embedded in Vectashield with DAPI (Vector). Images were taken using an ORKA-ER CCD camera (Hamamatsu Photonics) and an Axioskop 2 microscope (Zeiss), and subsequently analysed using I[mage]{.smallcaps}J.

(g). AKT and FOXO protein detection {#s2g}
-----------------------------------

Anti-phospho-Drosophila Akt (no. 4054) and Akt (no. 9272) antibodies were purchased from New England BioLab (UK distributor for The Cell Signalling). Anti-dFOXO is described in [@RSPB20090778C17]. Five flies were homogenized with 200 µl of 1× sample buffer containing proteinase inhibitor and phosphatase inhibitor cocktail I (Sigma). SDS--PAGE analysis was performed using a BioRad mini gel system and the proteins were transferred to a membrane by semidry blotter. Primary AKT antibodies were used at 1∶1000 dilution and the dFOXO primary antibody at a dilution of 1∶000. A secondary antibody conjugated with HRP was used at 1∶10 000, and the signal developed using an ECL detection kit (GE Healthcare).

(h). Statistical analyses {#s2h}
-------------------------

Statistical analyses were performed using JMP (v. 7) software (SAS Institute). Lifespan data were subjected to log-rank tests and are presented as survival curves. Weight, fecundity, TAG levels and fat-cell number data were tested for normality using the Shapiro--Wilk *W*-test on studentized residuals ([@RSPB20090778C56]). Two-way (genotype, *Wolbachia* status) analyses of variance (ANOVA) were performed and planned comparisons of means were made using the Tukey HSD test or Student\'s *t*, as appropriate. Data are presented as means of raw values ± s.e.m., and asterisk denotes significant difference from controls.

3.. Results {#s3}
===========

(a). Removal of *Wolbachia* enhances IGF-like signalling mutant phenotypes {#s3a}
--------------------------------------------------------------------------

To determine how *Wolbachia* infection status affects IIS, we characterized typical IIS-related phenotypes in *Wolbachia*-infected and -uninfected IIS mutant flies and their controls in parallel. IIS mutant flies were created by expression of a dominant negative form of the insulin receptor (UAS-InRDN) under the control of the ubiquitous and constitutive daughterless-GAL4 (daGAL4) driver.

Reduced growth and fecundity are typical phenotypes of lowered IIS and, as expected, daGAL4/InRDN females weighed significantly less and laid fewer eggs than their daGAL/+, InRDN/+ and *w* control genotypes, irrespective of *Wolbachia* status ([figure 1](#RSPB20090778F1){ref-type="fig"}*b*,*c*; and electronic supplementary material, figure 1*a*--*d*). However, removal of *Wolbachia* greatly accentuated the reduction in weight and fecundity of the daGAL4/InRDN genotype and moderately reduced these phenotypes in control genotypes ([figure 1](#RSPB20090778F1){ref-type="fig"}*b*,*c*; and [table 1](#RSPB20090778TB1){ref-type="table"} for statistical analysis by *Wolbachia* status).

###### 

Statistical comparisons of mean weight and fecundity data from [figure 1](#RSPB20090778F1){ref-type="fig"}*b*,*c* by *Wolbachia* status. Two-way ANOVAs were performed, which found genotype and *Wolbachia* status to be the main effects. Planned comparisons of mean weight and fecundity of *Wolbachia*-infected (Wol+) and -uninfected (Wol−) flies for each genotype were performed using the Tukey HSD.

  genotype       weight   fecundity                            
  -------------- -------- ----------- -------- ------- ------- --------
  *w*^Dah^       1.819    1.628       \<0.05   62.76   50.65   \<0.01
  InRDN/+        1.829    1.683       \<0.05   62.75   52.52   \<0.01
  daGAL4/+       1.83     1.661       \<0.05   63.72   49.08   \<0.01
  daGAL4/InRDN   1.239    0.728       \<0.05   27.7    1.98    \<0.01

Increases in TAG levels and alterations in adult fat tissue morphology are often associated with reduced IIS ([@RSPB20090778C3]; [@RSPB20090778C62]). Wol+ daGAL4/InRDN females had normal TAG levels ([figure 2](#RSPB20090778F2){ref-type="fig"}*a*) and adult fat body morphology ([figure 2](#RSPB20090778F2){ref-type="fig"}*b*) compared to Wol+ controls. In contrast, Wol− daGAL4/InRDN females had significantly higher TAG levels ([figure 2](#RSPB20090778F2){ref-type="fig"}*a*; Tukey HSD, *p* \< 0.05) and alterations in fat body morphology ([figure 2](#RSPB20090778F2){ref-type="fig"}*b*) compared to all other genotypes. Unlike the morphologically normal abdominal fat tissue of *Wolbachia*-infected daGAL4/InRDN and control flies ([figure 2](#RSPB20090778F2){ref-type="fig"}*b*(i--iii)), this tissue was misshapen and shrunken in Wol− daGAL4/InRDN flies ([figure 2](#RSPB20090778F2){ref-type="fig"}*b*(vi)), similar to that seen under starvation conditions ([@RSPB20090778C74]). For these IIS-related phenotypes, *Wolbachia* status had no effect on control genotypes ([figure 2](#RSPB20090778F2){ref-type="fig"}*a*,*b*).

![The effect of *Wolbachia* infection status on fat, survival and AKT phosphorylation. (*a*) TAG concentration of individual whole virgin females (*n* = 12). Wol+ *w*^Dah^ = 15.15 µg mg^−1^ of fly weight; Wol− *w*^Dah^ = 18.15 µg mg^−1^; Wol+ InRDN/+ = 14.38 µg mg^−1^; Wol− InRDN/+ = 15.74 µg mg^−1^; Wol+ daGAL4/dInRDN = 18.29 µg mg^−1^; Wol− daGAL4/dInRDN = 40.07 µg mg^−1^; Wol+ daGAL4/+ = 12.25 µg mg^−1^; and Wol− daGAL4/+ = 14.37 µg mg^−1^. Data were subjected to two-way ANOVA, with genotype (*p* \< 0.0001) and *Wolbachia* status (*p* \< 0.0001) having significant effects. There was a significant interaction effect of genotype and *Wolbachia* status (*p* \< 0.0001). Planned comparisons of the mean TAG level by genotype/*Wolbachia* status were made using the Tukey HSD. Error bars are s.e.m. and asterisk indicates significant difference from all groups, *p* \< 0.05. Black bars, *Wolbachia*-infected; grey bars, -uninfected. (*b*) Adult abdominal fat body morphology for each genotype: (i) Wol+ InRDN/+; (ii) Wol+ daGAL4/+; (iii) Wol+ daGAL4/InRDN; (iv) Wol− InRDN/+; (v) Wol− daGAL4/+; (vi) Wol− daGAL4/InRDN. Arrow indicates area of missing tissue and scale bar is 20 µm. (*c*) Survival of *Wolbachia*-infected and -uninfected daGAL4/InRDN once-mated females and controls. Median lifespans and statistical analyses are given in [table 2](#RSPB20090778TB2){ref-type="table"}. Red solid line, daGAL4/InRDN Wol+; red dashed line, daGAL4/InRDN Wol−; dark blue solid line, daGAL4 Wol+; dark blue dashed line, daGAL4 Wol−; green solid line, InRDN Wol+; green dashed line, InRDN Wol−; light blue solid line, *w* Wol+; light blue dashed line, *w* Wol−. (*d*) Levels of AKT and dFOXO phosphorylation were detected by Western blotting. For AKT phosphorylation, representative blots of two independent experiments each for Wol+ and Wol− backgrounds are shown. The upper two bands of each panel are phospho-AKT (pAKT) and the bottom two bands are tAKT. The presence of two bands is due to expression of two isoforms of AKT. pAKT/tAKT relative ratio was estimated from the signal intensity of the lower bands of both pAKT and AKT, which was averaged by ROI analysis in I[mage]{.smallcaps}J. For dFOXO phosphorylation in the Wol− background, a single experiment was performed. The ratio of phosphorylated to unphosphorylated dFOXO (dFOXO~ppp~/dFOXO ratio) was estimated from the intensity of the upper (dFOXO~ppp~) to the lower (dFOXO) band in I[mage]{.smallcaps}J.](rspb20090778f02){#RSPB20090778F2}

Lifespan is another trait that responds to changes in IIS and the effect of reducing the activity of the pathway can be either positive or negative. Some mutations or genetic manipulations of IIS, such as strong, ubiquitous downregulations, are often detrimental to lifespan ([@RSPB20090778C9]; [@RSPB20090778C62]; [@RSPB20090778C61]; [@RSPB20090778C53]), but moderate or tissue-specific reductions in IIS can extend it ([@RSPB20090778C9]; [@RSPB20090778C62]; [@RSPB20090778C16]; [@RSPB20090778C26]; [@RSPB20090778C6]; [@RSPB20090778C53]). It appears that alterations of specific IIS components at particular times or in specific tissues may be important, or that lifespan may peak at an intermediate level of IIS activity. Interestingly, Wol+ daGAL4/UAS-InRDN once-mated females showed a large extension of median and maximum lifespan ([figure 2](#RSPB20090778F2){ref-type="fig"}*c*; [table 2](#RSPB20090778TB2){ref-type="table"} for statistical analysis; electronic supplementary material, figure 2*a*), whereas Wol− daGAL4/InRDN females were very short-lived ([figure 2](#RSPB20090778F2){ref-type="fig"}*c*; [table 2](#RSPB20090778TB2){ref-type="table"} for statistical analysis; electronic supplementary material, figure 2*b*). For control genotypes, *Wolbachia* infection status had no effect on lifespan ([figure 2](#RSPB20090778F2){ref-type="fig"}*c*; [table 2](#RSPB20090778TB2){ref-type="table"} for statistical analysis; electronic supplementary material, figure 2*a*--*c*). This effect of *Wolbachia* removal to drastically shorten the lifespan of daGAL4/UAS-InRDN females is consistent with an accentuation of the inhibitory effect of InRDN expression, resulting in a reduction in IIS to levels detrimental to survival. The effect of over-expression of InRDN on lifespan of males in the Wol+ strain was also measured, and a slight reduction in median lifespan was found (electronic supplementary material, figure 2*d*). This detrimental effect of InRDN expression to male lifespan appeared to be accentuated in the absence of *Wolbachia* as only very few Wol− daGAL4/UAS-InRDN males enclosed, and those that did died within a few days. This sex difference in the effect on survival is typical for IIS mutants in *Drosophila* ([@RSPB20090778C9]; [@RSPB20090778C62]; [@RSPB20090778C16]; [@RSPB20090778C6]) and in mice ([@RSPB20090778C24]; [@RSPB20090778C53]).

###### 

Median and maximum lifespans and statistical comparisons of survivorship data from [figure 2](#RSPB20090778F2){ref-type="fig"}*c*. Each pairwise comparison of survivorship data by genotype and *Wolbachia* infection status was made using the log-rank test, and χ^2^ *p*-values are given.

  genotype/*Wolbachia* status   daGAL/InRDN+   daGAL/InRDN−    daGAL+          InRDN−          daGAL−          InRDN+          *w*−            *w*+
  ----------------------------- -------------- --------------- --------------- --------------- --------------- --------------- --------------- ----------------
  median lifespan (days)        70.5           21.4            54.0            54.0            49.0            45.5            54.0            54.0
  maximum lifespan (days)       82             36.0            66.0            65.0            63.0            66.0            69.0            66.0
  daGAL/InRDN+                                 2.197×10^−36^   1.632×10^−16^   3.861×10^−17^   1.853×10^−19^   3.707×10^−18^   2.923×10^−13^   1.488×10^−13^
  daGAL/InRDN−                                                 3.695×10^−35^   5.675×10^−29^   2.102×10^−32^   2.073×10^−31^   6.635×10^−27^   1.417E×10^−25^
  daGAL+                                                                       0.2081          0.00976         0.08486         0.46632         0.75395
  InRDN−                                                                                       0.20105         0.52295         0.12628         0.20625
  daGAL−                                                                                                       0.88930         0.01548         0.03060
  InRDN+                                                                                                                       0.06816         0.19695
  *w*−                                                                                                                                         0.67115
  *w*+                                                                                                                                         

The previous data suggested that *Wolbachia* acts to enhance IIS. As a further indicator of a change in the magnitude of IIS downregulation in daGAL4/UAS-InRDN flies owing to *Wolbachia* infection, the activation of two key downstream effectors of IIS---AKT and the fly forkhead box O transcription factor, dFOXO---were measured. The Ser505 of AKT is a target of the TOR/RICTOR complex, the phosphorylation of which is required for the full activation of the AKT protein ([@RSPB20090778C52]) and which is used as an indicator of AKT activity ([@RSPB20090778C21]). We measured the phosphorylation state of this serine using an antibody specific to the phosphoS505-AKT form of the protein (pAKT) and an antibody to total AKT (tAKT) (which recognizes both phosphorylated and unphosphorylated forms of AKT) in Wol+ and Wol− flies in Western blots. The level of AKT activation was then estimated by normalizing the pAKT signal to the tAKT signal. Only Wol− daGAL4/InRDN females showed a reduced pAKT/tAKT ratio compared with controls in two independent experiments ([figure 2](#RSPB20090778F2){ref-type="fig"}*d*), suggesting that the downregulation of IIS owing to daGAL4-driven expression InRDN was stronger in the absence of *Wolbachia* than in its presence. Active AKT phosphorylates dFOXO, and this phosphorylation retards the migration of dFOXO on SDS--PAGE ([@RSPB20090778C47]). To confirm the reduction in AKT activity in Wol− daGAL4/InRDN females, we examined levels of phosphorylated dFOXO. Indeed, consistent with a reduction in AKT activity in the Wol− daGAL4/InRDN females, we observed a decrease in the ratio of slower-migrating/phosphorylated to faster-migrating/unphosphorylated dFOXO in these flies ([figure 2](#RSPB20090778F2){ref-type="fig"}*d*).

Interestingly, the enhanced IIS-related phenotypes of the Wol− daGAL4/InRDN females resembled those due to a strong downregulation of the pathway obtained using daGAL-driven expression of UAS-PTEN. The essential function of the phosphoinositide phosphatase PTEN is to antagonize the effects of PI3K by dephosphorylation of the second messenger phosphatidylinositol-3,4,5-trisphosphate (PIP~3~; [@RSPB20090778C59]). UAS-PTEN expression thus downregulates IIS by converting PIP~3~ to PIP~2~ ([@RSPB20090778C18]; [@RSPB20090778C36]). Even in the presence of *Wolbachia*, daGAL/UAS-PTEN flies showed severe IIS-related phenotypes including growth, fecundity, fat and AKT phosphorylation, and they were very short-lived (electronic supplementary material, figures 1--3).

Taken together, these data suggest that the removal of the endosymbiont *Wolbachia* from daGAL4/InRDN females caused a greater inhibitory effect of InRDN expression on IIS, resulting in enhanced IIS-related phenotypes. The similar but less pronounced reduction in weight and fecundity seen upon removal of *Wolbachia* from control genotypes suggests that these two phenotypes may be the most sensitive to changes in IIS and demonstrates that *Wolbachia*\'s effect is not specific to the daGAL4/InRDN genotype.

(b). Removal of *Wolbachia* enhances the effect of expression of InRDN in adult fat body {#s3b}
----------------------------------------------------------------------------------------

The quantitatively different effects of InRDN expression on IIS-related phenotypes in the presence and absence of *Wolbachia*, described above, suggested a dose dependency of IIS downregulation. To begin to determine if these effects are general, we used the RU486 GeneSwitch-inducible GAL/UAS system ([@RSPB20090778C43]; [@RSPB20090778C49]) to express InRDN in adult fat body. Manipulation of IIS by over-expression of the key IIS effector forkhead transcription factor, dFOXO, in this tissue using the inducible S~1~106-GS driver has previously been shown to be sufficient to extend lifespan ([@RSPB20090778C16]). This driver was initially reported as expressed in adult fat body ([@RSPB20090778C49]) and has since been shown also to express in the digestive system and testes ([@RSPB20090778C46]).

Expression of InRDN using the S~1~106-GS driver under the same induction conditions as in [@RSPB20090778C16] had no effect on lifespan in the presence of *Wolbachia* ([figure 3](#RSPB20090778F3){ref-type="fig"}*a*). However, removal of *Wolbachia* from S~1~106-GS/UAS-InRDN female flies resulted in extension of lifespan and revealed a dose-dependent effect of expression of InRDN ([figure 3](#RSPB20090778F3){ref-type="fig"}*b*). At 200 µM, RU486 inducer Wol− S~1~106-GS/UAS-InRDN females showed a 6.5 per cent increase in median lifespan (χ^2^ *p* = 1.16×10^−7^) and at 300 µM RU486 a 13 per cent increase (χ^2^ *p* = 3.65×10^−15^) compared with the same genotype at 0 µM RU486. There was no effect of RU486 on survival of driver control female flies (electronic supplementary material, figure 4). S~1~106-GS/InRDN expression had no effect on fecundity or lipid levels (electronic supplementary material, figure 5), confirming the previous study modulating IIS in this tissue (Giannakou *et al*. [@RSPB20090778C16], [@RSPB20090778C17]). pAKT levels in the long-lived Wol− S~1~106-GS/InR-DN females were found to be indistinguishable from controls (electronic supplementary material, figure 5).

![Expression of InRDN in the abdominal adult fat body extends lifespan only in the absence of *Wolbachia*. Lifespan experiments were done in (*a*) *Wolbachia*-infected and (*b*) *Wolbachia-*uninfected flies. (*a*) Survival of Wol+ S~1~,106-GS/InRDN females was not affected by administration of 200 µM of RU486 inducer. The median lifespan was 56 days (*n* = 185) in the absence of the drug and 56 days (*n* = 188) in the presence of the drug. Open circles, S106/InRDN RU−; filled circles, S106/InRDN RU+. (*b*) Survival of Wol-S~1~,106-GS/InRDN on 200 and 300 µM RU486 concentrations compared with uninduced genetically identical flies (0 µM RU486). Individual median lifespans were 61 days on 0 µM (*n* = 141), 65 days on 200 µM (*n* = 137, χ^2^ *p* = 1.16 × 10^−7^) and 69 days on 300 µM (*n* = 130, χ^2^ *p* = 3.65 × 10^−15^). Crosses, S106/InRDN RU−; filled squares, S106/InRDN 200; filled diamonds, S106/InRDN 300.](rspb20090778f03){#RSPB20090778F3}

These data suggest that removal of *Wolbachia* from Wol+ normal-lived S~1~106-GS/InRDN females acted to increase the inhibitory effect of InRDN in this tissue to a threshold sufficient for lifespan extension. The data further suggest that ubiquitous expression of InRDN by daGAL4 may have affected fecundity, growth and fat phenotypes via expression during development and/or in other tissues.

5.. Discussion {#s4}
==============

The data presented here demonstrate that mutant IIS and its consequent phenotypes in *Drosophila* can be enhanced by removal of *Wolbachia*, suggesting that one of the normal consequences of *Wolbachia* infection is enhanced IIS. The data are consistent with a general effect on IIS, and not a specific interaction with mutants such as the daGAL4/InRDN genotype, because removal of *Wolbachia* from control strains had similar, although weaker, effects. More work will be needed both to determine the generality of these kinds of effects and exactly how *Wolbachia* modifies IIS-related phenotypes.

Evolutionary considerations suggest that the mechanisms by which *Wolbachia* interacts with IIS may have its origin in the way that these endosymbionts are transmitted. Their habitat is inside the cytoplasm of cells, and they are transmitted maternally, via infection of eggs ([@RSPB20090778C60]). *Wolbachia* are thought to persist in host populations by providing females with a reproductive advantage via mechanisms that can include male killing, feminization of genetic males and cytoplasmic incompatibility (see [@RSPB20090778C60] for review). In *D. melanogaster*, an effect of *Wolbachia* infection is to confer reproductive advantage through cytoplasmic incompatibility ([@RSPB20090778C22]). *Wolbachia*-infected females can successfully mate with infected or uninfected males, but uninfected females are incompatible with infected males. Thus, *Wolbachia* infection can spread and persist in the host population, although other mechanisms must also be involved ([@RSPB20090778C42]; [@RSPB20090778C15]; [@RSPB20090778C69]; [@RSPB20090778C7]).

In evolutionary terms, the interests of the female host and of the symbiont in host egg production are identical. Both host and symbiont are selected to maximize host fitness through this route. In populations of flies that are infected with *Wolbachia*, part of the response to selection for an optimal regime of host egg production through the life history may thus be attributable to evolution of the effects of the symbiont on host reproduction. However, this alone would not explain why *Wolbachia* would act as seen in this study, solely to promote *high* host fecundity. A possible explanation could come from events during adaptation to life in the laboratory. The life history of *Drosophila* evolves so as to optimize fitness under the prevailing culture regime ([@RSPB20090778C54]; [@RSPB20090778C57]). The usual regime consists of the transfer of young adults to fresh culture vials, with consequent selection for rapid maturation and copious early reproduction. This produces evolutionary increases in the speed of pre-adult development and in female fecundity relative both to the levels seen in wild flies and in laboratory stocks maintained with overlapping generations. These traits that are favoured in laboratory culture are also promoted by increased IIS, although it has not yet been determined whether laboratory adaptation is achieved in whole or in part by increased activity of this pathway. In stocks that are infected with *Wolbachia*, part of the adaptation to laboratory conditions may be achieved by the evolution of the symbiont so as to alter host physiology in ways that promote an optimal regime of egg production through copious, early female reproduction. One prediction of the hypothesis is that these effects of *Wolbachia* would be expected to be particularly obvious in strains that have undergone laboratory adaptation, in traits promoting fitness through the regime of fecundity and in females. Alternatively, interactions of IIS with the *Wolbachia* infection itself could play a role.

The tetracycline treatment used for the removal of *Wolbachia* has itself been found to result in a decline of mitochondrial activity and increase in mitochondrial DNA density, which may increase insulin insensitivity regardless of the removal of the endosymbionts ([@RSPB20090778C1]). However, this study measured the effects only two generations after treatment and, because the effect is based on damage to the mitochondria, it is expected to decline rapidly. The parental strains used in the current study were reared on normal food for at least five generations following tetracycline treatment to restore flora in their intestine prior to the generation of experimental flies for analysis. That such a regime does not produce ill-effects as a result of the tetracycline treatment itself is supported by the finding that tetracycline treatment of already-*Wolbachia*-free flies had no effect on lifespan when tested several generations after treatment ([@RSPB20090778C64]).

The variability of the phenotypes owing to IIS reduction in the fly is probably due to the complex nature of the pathway itself, as well as the developmental stage and tissue affected by the genetic manipulation in question. However, the dose dependency of IIS downregulation identified here supports the idea that some of the variability could be related to differing strengths of IIS downregulation. Over-expression of the FOXO transcription factor in the fly eye imaginal disks induced cell death ([@RSPB20090778C30]), whereas the same gene expressed in the adult fat body extended lifespan ([@RSPB20090778C16]; [@RSPB20090778C26]). It is not known what intracellular differences exist between the adult fat body and imaginal disks that separate FOXO\'s longevity function from its apoptotic function, but a likely explanation could be differences in the level of FOXO activation in the two systems. Interestingly, a measurable reduction of AKT phosphorylation correlated with malformation of the adult fat body, sterility and shortened lifespan, which, given the role of AKT activity in preventing apoptosis, could suggest that the short lifespan of the *pkb*^*3*^ mutant was due to its reduced AKT activity level ([@RSPB20090778C59]).

Despite the uncertainties as to the mechanism by which IIS is modified, the *Wolbachia* effect has implications for studies of IIS in *Drosophila*. It is desirable to ensure that the *Wolbachia* status of all strains being compared is the same, to rule out any possibility that traits apparently attributable to altered IIS are in fact owing to differences in *Wolbachia* status. However, provided this stricture is observed, alteration in *Wolbachia* status could be a convenient way of altering the intensity of IIS. The initial state of IIS as well as the stage and tissue specificity of the IIS manipulation may determine how a change in *Wolbachia* status affects IIS phenotypes.

6.. Conclusion {#s5}
==============

The data presented here show that the effects of mutant IIS are dose-dependent, and that *Wolbachia* acts to enhance IIS, thus modifying the extent to which IIS mutants affect signalling and the consequent pleiotropic phenotypes of the pathway. Furthermore, for some of these phenotypes, such as lifespan, the phenotype peaks at an intermediate level of IIS downregulation.
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